Clinical trials: Antithrombin III Deficiency
Antithrombin Deficiency Type 2
Response of Continuous Recombinant Antithrombin Infusion in Postcardiotomy ECMO Patients
The objective of this study will be to prospectively evaluate the response of a continuous infusion of recombinant human antithrombin concentrate (rhAT) (ATRYN®) to achieve and maintain the AT activity within a specified range in…
- Trial name
- NCT03090893
- Testing
- ATryn continuous infusion
- Volunteers
- healthy volunteers welcome
- Sponsor
- Mayo Clinic